Eli Lilly and Company intends to acquire Novartis Animal Health in a $5.4 billion all-cash transaction that will make Lilly’s own animal health business, Elanco the world’s second-largest animal health company.
Jeff Simmons, senior vice president of Eli Lilly and Company and president of Elanco Animal Health, joined Lilly’s chairman, president and chief executive officer John Lechleiter in making the official announcement this morning. Lilly CEO John Lechleiter and Elanco president Jeff Simmons announce Novartis deal